Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 2
1949 1
1950 2
1952 1
1953 3
1954 3
1955 1
1956 1
1957 1
1958 4
1959 3
1960 3
1961 2
1962 6
1963 7
1964 17
1965 6
1966 6
1967 16
1968 14
1969 12
1970 17
1971 16
1972 26
1973 41
1974 48
1975 32
1976 40
1977 41
1978 63
1979 60
1980 69
1981 84
1982 95
1983 76
1984 108
1985 141
1986 119
1987 146
1988 167
1989 138
1990 156
1991 161
1992 168
1993 142
1994 124
1995 125
1996 132
1997 110
1998 124
1999 139
2000 140
2001 158
2002 172
2003 156
2004 128
2005 158
2006 165
2007 190
2008 147
2009 166
2010 165
2011 160
2012 190
2013 186
2014 176
2015 172
2016 212
2017 180
2018 194
2019 184
2020 191
Text availability
Article attribute
Article type
Publication date

Search Results

6,255 results
Results by year
Filters applied: . Clear all
Page 1
Sulfasalazine: a review of its use in the management of rheumatoid arthritis.
Plosker GL, Croom KF. Plosker GL, et al. Drugs. 2005;65(13):1825-49. doi: 10.2165/00003495-200565130-00008. Drugs. 2005. PMID: 16114981 Review.
Sulfasalazine was associated with broadly similar efficacy to that of various other DMARDs in several randomised, double-blind, comparative trials. ...Sulfasalazine has a relatively short lag time until its onset of action and is often considered to be among the mor
Sulfasalazine was associated with broadly similar efficacy to that of various other DMARDs in several randomised, double-blind, compa
Novel analogs of sulfasalazine as system x(c) (-) antiporter inhibitors: Insights from the molecular modeling studies.
Patel D, Kharkar PS, Gandhi NS, Kaur E, Dutt S, Nandave M. Patel D, et al. Drug Dev Res. 2019 Sep;80(6):758-777. doi: 10.1002/ddr.21557. Epub 2019 Jun 14. Drug Dev Res. 2019. PMID: 31199023
Erastin, sorafenib, and sulfasalazine (SSZ) are a few of the established inhibitors of Sx(c) (-) . However, its pharmacological inhibition with novel and potent agents is still very much required due to potential issues, for example, potency, bioavailability, and blood-bra …
Erastin, sorafenib, and sulfasalazine (SSZ) are a few of the established inhibitors of Sx(c) (-) . However, its pharmacological inhib …
A solid-phase luminescence sensor based on molecularly imprinted polymer-CdSeS/ZnS quantum dots for selective extraction and detection of sulfasalazine in biological samples.
Ahmadpour H, Hosseini SMM. Ahmadpour H, et al. Talanta. 2019 Mar 1;194:534-541. doi: 10.1016/j.talanta.2018.10.053. Epub 2018 Oct 24. Talanta. 2019. PMID: 30609569
MIP and Non-imprinted polymer (NIP) with the recognition site for Sulfasalazine (SSZ) were synthesized and attached to the immobilized QDs. A trace amount of sulfasalazine was determined using fluorescence spectroscopy method based on quenching effect of sulfasal
MIP and Non-imprinted polymer (NIP) with the recognition site for Sulfasalazine (SSZ) were synthesized and attached to the immobilize …
Evolution of olsalazine.
Truelove SC. Truelove SC. Scand J Gastroenterol Suppl. 1988;148:3-6. doi: 10.3109/00365528809101538. Scand J Gastroenterol Suppl. 1988. PMID: 2906475 Review.
Studies into the metabolism of sulphasalazine have shown that, when taken orally, most of the ingested dose reaches the colon intact, and within the colonic lumen, bacteria split sulphasalazine into two breakdown products, sulphapyridine and 5-ASA. 5-ASA was shown t …
Studies into the metabolism of sulphasalazine have shown that, when taken orally, most of the ingested dose reaches the colon intact, …
Sulfasalazine and its metabolites inhibit platelet function in patients with inflammatory arthritis.
MacMullan PA, Madigan AM, Paul N, Peace AJ, Alagha A, Nolan KB, McCarthy GM, Kenny D. MacMullan PA, et al. Clin Rheumatol. 2016 Feb;35(2):447-55. doi: 10.1007/s10067-014-2769-x. Epub 2014 Sep 26. Clin Rheumatol. 2016. PMID: 25253538
A total of 32 patients were investigated, 15 taking sulfasalazine and 17 taking other disease-modifying anti-rheumatic drugs (DMARDs) and no sulfasalazine. ...The inhibition of AA-induced platelet aggregation by sulfasalazine is comparable to that achieved by …
A total of 32 patients were investigated, 15 taking sulfasalazine and 17 taking other disease-modifying anti-rheumatic drugs (DMARDs) …
Sulphasalazine and lung toxicity.
Parry SD, Barbatzas C, Peel ET, Barton JR. Parry SD, et al. Eur Respir J. 2002 Apr;19(4):756-64. doi: 10.1183/09031936.02.00267402. Eur Respir J. 2002. PMID: 11999006 Free article. Review.
Sulphasalazine prescribing is on the increase. Pulmonary toxicity and blood dyscrasias are rare side-effects. Numerous case reports have been published implicating sulphasalazine in pulmonary toxicity. ...All published case reports/letters referring to sulphasala
Sulphasalazine prescribing is on the increase. Pulmonary toxicity and blood dyscrasias are rare side-effects. Numerous case reports h
Clinical pharmacokinetics of sulphasalazine.
Das KM, Dubin R. Das KM, et al. Clin Pharmacokinet. 1976 Nov-Dec;1(6):406-25. doi: 10.2165/00003088-197601060-00002. Clin Pharmacokinet. 1976. PMID: 15752 Review.
Sulphasalazine consists of 5-aminosalicylic acid and sulphapyridine both linked together by an azo bond. Sulphasalazine is clearly useful in long-term management of ulcerative colitis and may be useful in Crohn's disease. The absorption, metabolism and excretion of
Sulphasalazine consists of 5-aminosalicylic acid and sulphapyridine both linked together by an azo bond. Sulphasalazine is cle
Sulphasalazine in ulcerative colitis.
[No authors listed] [No authors listed] Drug Ther Bull. 1967 Nov 24;5(24):93-4. Drug Ther Bull. 1967. PMID: 4384228 Review. No abstract available.
Adverse effects of sulphasalazine.
Pullar T. Pullar T. Adverse Drug React Toxicol Rev. 1992 Summer;11(2):93-109. Adverse Drug React Toxicol Rev. 1992. PMID: 1353378 Review. No abstract available.
The history of the use of sulphasalazine in rheumatology.
Amos RS. Amos RS. Br J Rheumatol. 1995 Nov;34 Suppl 2:2-6. Br J Rheumatol. 1995. PMID: 8535643 Review.
Sulphasalazine was initially used more than 50 yr ago to treat inflammatory arthritis but fell into disuse, only to be revived 25 yr ago for rheumatoid arthritis. ...
Sulphasalazine was initially used more than 50 yr ago to treat inflammatory arthritis but fell into disuse, only to be revived 25 yr
6,255 results
Jump to page
Feedback